Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.

Guo X, Sun G, Xu Y, Zhou S, Song Q, Li Y, Ouyang N, Li G, Cheng Z, Ye N, Wang J, Zhou Y, Yang H, Shi C, Wang C, Liu S, Zhu W, Moran AE, Ning G, Bi Y, Wang W, Cai J, Li J, Sun Y, BPRULE Study Group

Open source

DOI: 10.1016/s0140-6736(25)01391-1
Published: 2025 Sep 6
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-01391-1,
  title = {Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.},
  author = {Guo X and Sun G and Xu Y and Zhou S and Song Q and Li Y and Ouyang N and Li G and Cheng Z and Ye N and Wang J and Zhou Y and Yang H and Shi C and Wang C and Liu S and Zhu W and Moran AE and Ning G and Bi Y and Wang W and Cai J and Li J and Sun Y and BPRULE Study Group},
  year = {2025},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(25)01391-1},
  url = {https://doi.org/10.1016/s0140-6736(25)01391-1}
}

RIS

TY  - JOUR
TI  - Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.
AU  - Guo X
AU  - Sun G
AU  - Xu Y
AU  - Zhou S
AU  - Song Q
AU  - Li Y
AU  - Ouyang N
AU  - Li G
AU  - Cheng Z
AU  - Ye N
AU  - Wang J
AU  - Zhou Y
AU  - Yang H
AU  - Shi C
AU  - Wang C
AU  - Liu S
AU  - Zhu W
AU  - Moran AE
AU  - Ning G
AU  - Bi Y
AU  - Wang W
AU  - Cai J
AU  - Li J
AU  - Sun Y
AU  - BPRULE Study Group
PY  - 2025
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(25)01391-1
UR  - https://doi.org/10.1016/s0140-6736(25)01391-1
ER  -

APA

X, G., G, S., Y, X., S, Z., Q, S., Y, L., N, O., G, L., Z, C., N, Y., J, W., Y, Z., H, Y., C, S., C, W., S, L., W, Z., AE, M., G, N., Y, B., W, W., J, C., J, L., Y, S., & Group, B. S. (2025). Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)01391-1

Source records

pubmed · retrieved 2026-09-25T17:35:15.427Z